13D/13G Filings - Societe des Produits Nestle S.A.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-02
5:16 pm
Purchase
2022-12-31 13G Axcella Health Inc.
AXLA
Societe des Produits Nestle S.A. 444,218
15.090%
271,996increase
(+157.93%)
Filing
History
2022-10-19
3:22 pm
Purchase
2022-10-17 13G ChromaDex Corporation
CDXC
Societe des Produits Nestle S.A. 3,816,794
5.110%
3,816,794increase
(New Position)
Filing
History
2021-02-12
1:52 pm
Purchase
2020-12-31 13G Axcella Health Inc.
AXLA
Societe des Produits Nestle S.A. 172,222
11.470%
172,222increase
(New Position)
Filing
History
2020-10-13
10:48 am
Sale
2020-10-13 13D AIMMUNE THERAPEUTICS INC
AIMT
Societe des Produits Nestle S.A. 100
100.000%
-12,813,147decrease
(-100.00%)
Filing
History
2020-08-31
06:47 am
Purchase
2020-08-31 13D AIMMUNE THERAPEUTICS INC
AIMT
Societe des Produits Nestle S.A. 12,813,247
19.600%
12,813,247increase
(New Position)
Filing
History